Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel R-Spondin2 RNA Fusion and NTRK3 Mutation

Ampullary adenocarcinoma is a rare malignancy that lacks standard systemic treatment. We describe a case of recurrent metastatic ampullary adenocarcinoma of the pancreaticobiliary subtype treated with nanoparticle albumin-bound (nab)-paclitaxel and gemcitabine as first-line treatment. This report al...

Descripción completa

Detalles Bibliográficos
Autores principales: Linscott, Maryknoll P., Markus, Havell, Sennett, Mackenzie, Abendroth, Catherine, Yee, Nelson S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452745/
https://www.ncbi.nlm.nih.gov/pubmed/37626821
http://dx.doi.org/10.3390/biomedicines11082326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452745/
https://www.ncbi.nlm.nih.gov/pubmed/37626821
http://dx.doi.org/10.3390/biomedicines11082326

Ejemplares similares